A Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Diabetic Patients.
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 558 participants.
Also called NCT02156349
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 558 participants
- Registry
-
NCT02156349
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Germany
- Registry status
- Completed
Technical summary
Registry record NCT02156349. Randomized; no masking; primary purpose diagnostic. Start 2014-05-14 (actual); primary completion 2017-04-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Diabetic Patients.
- Acronym
- PDMProValueDSP
- Condition
- Type II Diabetes Mellitus
- Intervention (Device)
- Accu-Chek Smart Pix Software
- Intervention (Device)
- Accu-Chek Smart Pix readout Device
- Lead sponsor
- Hoffmann-La Roche
- Collaborator
- Roche Diabetes Care
Record details
- Record id
cardio:ct-nct02156349- Content hash
497e5631efce3d5418c7346bc32bc30e95270a6d757d2501c95355e3d482cc05